Researchers comparing MOTS-c and 5-Amino-1MQ are usually mapping which compound fits a given metabolic-regulation research question. This is descriptive reference information about how they differ, not guidance or a recommendation. Both are sold strictly for in-vitro laboratory research and are not for human or veterinary use.
| MOTS-c | 5-Amino-1MQ | |
|---|---|---|
| Type | 16-amino-acid mitochondrial-derived peptide | Small-molecule NNMT enzyme inhibitor |
| Primary research area | AMPK signaling, mitochondrial-nuclear crosstalk | NNMT inhibition, cellular NAD+/methylation |
| Handling | Lyophilized; store frozen | Store frozen; dissolve for cell-culture work |
MOTS-c is a mitochondrial-derived peptide studied in metabolic-signaling and AMPK-pathway research in cell and rodent models.
MOTS-c product page and batch COA · MOTS-c reconstitution guide
5-Amino-1MQ is a small-molecule NNMT inhibitor used as a tool compound to probe NNMT activity in adipocyte and metabolic cell models.
5-Amino-1MQ product page and batch COA
Both are studied in metabolic-regulation research but act very differently: MOTS-c is a signaling peptide, 5-Amino-1MQ is an enzyme inhibitor. Researchers choose based on whether they are probing a signaling pathway or an enzyme target.
MOTS-c is a mitochondrial-derived signaling peptide; 5-Amino-1MQ is a small-molecule NNMT enzyme inhibitor. Different molecule types studied in different metabolic mechanisms.
Both appear in metabolic-regulation research, but they target different mechanisms (signaling vs. enzyme inhibition).
No. Both are sold strictly for in-vitro laboratory research and are not for human or veterinary use.